UK Warns of Pancreatitis, Deaths Tied to Wegovy, Mounjaro [View all]
Source: Bloomberg News
The UK warned some patients have died of severe inflammation of the pancreas linked to obesity and diabetes drugs such as Eli Lilly & Co.’s Mounjaro and Novo Nordisk A/S’s Wegovy.
Though the worst cases of pancreatitis were rare, the UK Medicines and Healthcare products Regulatory Agency said Thursday doctors and patients should know some incidents had been particularly severe, as it strengthened its warning over taking the drugs.
The guidance applies to medicines that mimic the GLP-1 gut hormone, like Wegovy, as well as drugs that also imitate a second hormone called GIP. Mounjaro falls in this category. Both already carry similar warnings in the US.
Novo said patients should only take these medications when under the supervision of a health professional who can advise on side effects, and that the benefit-risk profile of GLP-1 medicines remains positive.
Read more: https://www.bloomberg.com/news/articles/2026-01-29/uk-warns-of-severe-pancreatitis-deaths-linked-to-wegovy-mounjaro
The article emphasizes that the cases of severe pancreatitis were rare, and that these drugs should only be used under a doctors supervision.
About 25 million of these drugs have been dispensed, and within that pool, there were 19 deaths and 24 cases of pancreatitis reported.
= new reply since forum marked as read